Dr. Browning is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6035 Fairview Rd
Charlotte, NC 28210Phone+1 704-295-3000Fax+1 704-295-3186
Education & Training
- University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1985 - 1986
- Duke University HospitalResidency, Ophthalmology, 1982 - 1985
- Duke University HospitalInternship, Internal Medicine, 1981 - 1982
- Duke University School of MedicineClass of 1981
Certifications & Licensure
- NC State Medical License 1982 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Medflow EHR, Medflow, Inc., 2012-2013
- Top MD Consumers Checkbook
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
- Phase II Combination Steroid and Anti-VEGF for Persistent DME Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 125 citationsProgression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.Tiarnan D L Keenan, Elvira Agrón, Amitha Domalpally, Traci E. Clemons, Freekje van Asten
Ophthalmology. 2018-12-01 - 489 citationsPanretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol, Seidu Inusah, Lloyd Paul Aiello
JAMA. 2015-11-24 - 48 citationsCost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Re...David W. Hutton, Joshua D. Stein, Neil M. Bressler, Lee M. Jampol, David J. Browning
JAMA Ophthalmology. 2017-06-01
Press Mentions
- Pain Control After Intravitreal Injection Using Topical Nepafenac 0.3% or Pressure Patching: A Randomized, Placebo-Controlled TrialApril 29th, 2020
- Recapping Retina Subspecialty Day at the 2018 AAO Annual MeetingMarch 12th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: